CLC-3 regulates TGF-β/smad signaling pathway to inhibit the process of fibrosis in hypertrophic scar

被引:3
|
作者
Liang, Qian [1 ]
Pan, Fuqiang [1 ]
Qiu, Houhuang [1 ]
Zhou, Xiang [1 ]
Cai, Jieyun [1 ]
Luo, Ruijin [1 ]
Xiong, Zenghui [1 ]
Yang, Huawei [2 ]
Zhang, Liming [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 2, Dept Med Cosmetol, 166 Daxue East Rd, Nanning, Guangxi, Peoples R China
[2] Guangxi Med Univ, Affiliated Canc Hosp, Dept Breast Surg, 71 Hedi Rd, Nanning, Guangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Hypertrophic scar; HSFB; ClC-3; TGF-beta; 1/Smad3; INVASION; CHANNELS; MIGRATION; PROTECTS; CANCER; TISSUE; CELLS;
D O I
10.1016/j.heliyon.2024.e24984
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: To study the role and mechanism of chloride channel-3 (ClC-3) in the formation of hypertrophic scar by constructing ClC-3 interference vectors and examining their effects on human hypertrophic scar fibroblasts (HSFB). Methods: Human HSFB and human normal skin fibroblasts (NSFB) were used in this study, and ClC-3 interference vectors were constructed to transfect cells. ClC-3 inhibitors NPPB and Tamoxifen were used to treat cells. Cell migration and the expression of TGF-beta/Smad, CollagenI, CollagenIII were examined to explore the role of ClC-3 in the formation of hypertrophic scar. Results: Compared with the normal skin tissue, the positive expression of ClC-3 and TGF-beta in the scar tissue was significantly increased. The relative expression of ClC-3 and TGF-beta 1 in HSFB cells was higher than that in NSFB cells. Interfering with the expression of CLC-3 can inhibit the migration of HSFB cells and the expression of TGF- beta/Smad, CollagenI/III. The experiment of HSFB cells treated by CLC-3 inhibitors can also obtain similar results. Conclusion: Inhibiting CLC-3 can reduce the formation of hypertrophic scars.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Bioflavonoid Galangin Suppresses Hypertrophic Scar Formation by the TGF-β/Smad Signaling Pathway
    Ru, Zha
    Hu, Ying
    Huang, Shenghua
    Bai, Li
    Zhang, Kun
    Li, Yue
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [2] TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
    Yu, Xiao-Yong
    Sun, Qian
    Zhang, Ya-Mei
    Zou, Liang
    Zhao, Ying-Yong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] HOXC10 promotes hypertrophic scar fibroblast fibrosis through the regulation of STMN2 and the TGF-β/Smad signaling pathway
    Zhou, Xin
    Lin, Song
    HISTOCHEMISTRY AND CELL BIOLOGY, 2024, 162 (05) : 403 - 413
  • [4] Nap1l1 Regulates Cardiac Fibrosis in Hypertrophic Heart Disease by Regulating the TGF-β/Smad Signaling Pathway
    Liu, Yuxi
    Chen, Ruizhen
    Zou, Yunzeng
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C72 - C73
  • [5] Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-β-Independent Process
    Rodrigues Diez, Raul
    Rodrigues-Diez, Raquel
    Lavoz, Carolina
    Rayego-Mateos, Sandra
    Civantos, Esther
    Rodriguez-Vita, Juan
    Mezzano, Sergio
    Ortiz, Alberto
    Egido, Jesus
    Ruiz-Ortega, Marta
    PLOS ONE, 2010, 5 (11):
  • [6] Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation
    Zhang, Tao
    Wang, Xiao-Feng
    Wang, Zheng-Cai
    Lou, Dong
    Fang, Qing-Qing
    Hu, Yan-Yan
    Zhao, Wan-Yi
    Zhang, Li-Yun
    Wu, Li-Hong
    Tan, Wei-Qiang
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [7] TGF-β/Smad signaling in renal fibrosis
    Meng, Xiao-Ming
    Tang, Patrick Ming-Kuen
    Li, Jun
    Lan, Hui Yao
    FRONTIERS IN PHYSIOLOGY, 2015, 6
  • [8] TGF-β, Smad3 and the process of progressive fibrosis
    Gauldie, J.
    Bonniaud, P.
    Sime, P.
    Ask, K.
    Kolb, M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 661 - 664
  • [9] Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway
    Yingwen Bai
    Lulu Wang
    Lingyun TingYang
    Weihong Wang
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 2379 - 2391
  • [10] Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway
    Bai, Yingwen
    Wang, Lulu
    Yang, Ting
    Wang, Lingyun
    Ge, Weihong
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (10) : 2379 - 2391